BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 10525091)

  • 1. Role of an ATP-sensitive potassium channel opener, YM934, in mitochondrial energy production in ischemic/reperfused heart.
    Tanonaka K; Taguchi T; Koshimizu M; Ando T; Morinaka T; Yogo T; Konishi F; Takeo S
    J Pharmacol Exp Ther; 1999 Nov; 291(2):710-6. PubMed ID: 10525091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preservation of mitochondrial function by diazoxide during sustained ischaemia in the rat heart.
    Iwai T; Tanonaka K; Koshimizu M; Takeo S
    Br J Pharmacol; 2000 Mar; 129(6):1219-27. PubMed ID: 10725271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased mitochondrial K(ATP) channel activity during chronic myocardial hypoxia: is cardioprotection mediated by improved bioenergetics?
    Eells JT; Henry MM; Gross GJ; Baker JE
    Circ Res; 2000 Nov; 87(10):915-21. PubMed ID: 11073888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotective effects of YM934, an ATP-sensitive potassium channel opener, on stunned myocardium in anesthetized dogs.
    Taguchi T; Uchida W; Takenaka T; Takeo S
    Gen Pharmacol; 1999 Jun; 32(6):695-703. PubMed ID: 10401995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial uncoupling, with low concentration FCCP, induces ROS-dependent cardioprotection independent of KATP channel activation.
    Brennan JP; Southworth R; Medina RA; Davidson SM; Duchen MR; Shattock MJ
    Cardiovasc Res; 2006 Nov; 72(2):313-21. PubMed ID: 16950237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YM934, a novel K+ channel opener, activates ATP-sensitive K+ channels in cardiac myocytes.
    Yamada M; Terzic A; Findlay I; Jahangir A; Shen WK; Kurachi Y
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1544-9. PubMed ID: 8263816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicorandil preserves mitochondrial function during ischemia in perfused rat heart.
    Iwai T; Tanonaka K; Motegi K; Inoue R; Kasahara S; Takeo S
    Eur J Pharmacol; 2002 Jun; 446(1-3):119-27. PubMed ID: 12098593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic profiles of YM934, a novel potassium channel opener.
    Uchida W; Masuda N; Taguchi T; Shibasaki K; Shirai Y; Asano M; Matsumoto Y; Tsuzuki R; Fujikura T; Takenaka T
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):180-7. PubMed ID: 7511745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATP-dependent potassium channels involved in the cardiac protection induced by intermittent hypoxia against ischemia/reperfusion injury.
    Zhu HF; Dong JW; Zhu WZ; Ding HL; Zhou ZN
    Life Sci; 2003 Jul; 73(10):1275-87. PubMed ID: 12850243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyphenol (-)-epigallocatechin gallate during ischemia limits infarct size via mitochondrial K(ATP) channel activation in isolated rat hearts.
    Song DK; Jang Y; Kim JH; Chun KJ; Lee D; Xu Z
    J Korean Med Sci; 2010 Mar; 25(3):380-6. PubMed ID: 20191036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of mitochondrial K(ATP) modulators on cardioprotection induced by chronic high altitude hypoxia in rats.
    Neckár J; Szárszoi O; Koten L; Papousek F; Ost'ádal B; Grover GJ; Kolár F
    Cardiovasc Res; 2002 Aug; 55(3):567-75. PubMed ID: 12160954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of isosteviol against myocardium injury induced by ischaemia-reperfusion in the isolated guinea pig heart.
    Xu D; Zhang S; Foster DJ; Wang J
    Clin Exp Pharmacol Physiol; 2007; 34(5-6):488-93. PubMed ID: 17439420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischemic preconditioning reduces right ventricular infarct size through opening of mitochondrial potassium channels.
    Andersen A; Povlsen JA; Bøtker HE; Nielsen-Kudsk JE
    Cardiology; 2012; 123(3):177-80. PubMed ID: 23128893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondria are targets for geranylgeranylacetone-induced cardioprotection against ischemia-reperfusion in the rat heart.
    Shinohara T; Takahashi N; Kohno H; Yamanaka K; Ooie T; Wakisaka O; Murozono Y; Taniguchi Y; Torigoe Y; Hara M; Shimada T; Saikawa T; Yoshimatsu H
    Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1892-9. PubMed ID: 17586615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury.
    Lee SH; Yang MK; Lim JH; Seo HW; Yi KY; Yoo SE; Lee BH; Won HS; Lee CS; Choi WS; Shin HS
    Arch Pharm Res; 2008 Apr; 31(4):482-9. PubMed ID: 18449506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid-induced cardioprotection against myocardial infarction and arrhythmias: mitochondrial versus sarcolemmal ATP-sensitive potassium channels.
    Fryer RM; Hsu AK; Nagase H; Gross GJ
    J Pharmacol Exp Ther; 2000 Aug; 294(2):451-7. PubMed ID: 10900218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against ischemia-induced ventricular arrhythmias and myocardial dysfunction conferred by preconditioning in the rat heart: involvement of mitochondrial K(ATP) channels and reactive oxygen species.
    Matejíková J; Kucharská J; Pintérová M; Pancza D; Ravingerová T
    Physiol Res; 2009; 58(1):9-19. PubMed ID: 18198991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic characterization of BMS-191095, a mitochondrial K(ATP) opener with no peripheral vasodilator or cardiac action potential shortening activity.
    Grover GJ; D'Alonzo AJ; Garlid KD; Bajgar R; Lodge NJ; Sleph PG; Darbenzio RB; Hess TA; Smith MA; Paucek P; Atwal KS
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1184-92. PubMed ID: 11356945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcolemmal and mitochondrial K(atp)channels mediate cardioprotection in chronically hypoxic hearts.
    Kong X; Tweddell JS; Gross GJ; Baker JE
    J Mol Cell Cardiol; 2001 May; 33(5):1041-5. PubMed ID: 11343425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial K(ATP) channel as an end effector of cardioprotection during late preconditioning: triggering role of nitric oxide.
    Wang Y; Kudo M; Xu M; Ayub A; Ashraf M
    J Mol Cell Cardiol; 2001 Nov; 33(11):2037-46. PubMed ID: 11708847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.